hasApprovedDrug

URI: https://gptkb.org/prop/hasApprovedDrug

105 triples

GPTKB property

approvedDrug • approvedDrugForm • firstApprovedDrug

Subject	Object
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Alpelisib
gptkb:HMG_CoA_reductase_inhibitors_(statins)	gptkb:lovastatin
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Cisplatin
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Brigatinib
gptkb:small_interfering_RNA_(siRNA)	gptkb:Givosiran
gptkb:Immune_Checkpoint_Blockade	gptkb:Nivolumab
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Tislelizumab
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Anlotinib
gptkb:plasminogen_activator,_tissue_type	gptkb:tenecteplase
gptkb:Erythropoietins	gptkb:darbepoetin_alfa
gptkb:BRAF_inhibitors	gptkb:sorafenib
gptkb:BRAF_inhibitors	gptkb:encorafenib
gptkb:KRAS_G12C_inhibitors	gptkb:sotorasib
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Tremelimumab
gptkb:SGLT2_inhibitors	gptkb:ertugliflozin
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Trastuzumab_deruxtecan
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Lorlatinib
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Nivolumab
gptkb:Non-Small_Cell_Lung_Cancer	gptkb:Amivantamab
gptkb:T_Cell_Therapy	gptkb:Yescarta